QuasarEdge Acquisition

This report solidifies the trust value and capital deployment ahead of the July 16, 2027 business combination expiration. Public shareholders are contractually entitled to redeem shares for a pro-rata portion of the trust, which the notes calculate as initially $10.05 per public unit (or $10.00 per share plus interest/earnings per the charter). The sponsor agreed to waive redemption rights for founder and private shares and guaranteed liability to protect the trust if third-party vendor claims reduce assets below $10.00 per public share. Auditor Simon & Edward, LLP explicitly disclosed 'substantial doubt about the Company’s ability to continue as a going concern' citing the limited 15-month operational runway. Furthermore, underwriter Polaris Advisory Partners secured a 0.50% cash discount ($575,000 upon full over-allotment) and 230,000 ordinary shares as deferred compensation, alongside a 36-month right of first refusal for future advisory engagements.

Mechanically, the filing verifies the sponsor/affiliate share count that sits outside the redemption pool and does not participate in the per-share trust balance ($10.06) circulating through public holders ahead of the 2027-07-16 deadline. Investors tracking redemption calendars, trust value, and sponsor conduct now have a confirmed baseline for the 4,025,000 non-redeemable shares, which fixes the promoter’s equity exposure and defines the non-redeemable denominator alongside the public float. Substantively, the filing makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; it is strictly a compliance artifact recording static beneficial ownership.

This is the definitive IPO closing disclosure for QRED. The key structural terms are now established: $10.05 per share in trust (a slight premium over $10.00/market convention for a 2026 vintage SPAC), a 15-month deadline with no stated extension mechanism, and standard 180-day founder lock-up and 30-day private placement lock-up. The trust/share figure of $10.05 is slightly above the $10.00 IPO price, meaning the trust has roughly $0.05/share of initial cushion from the private placement proceeds beyond the standard amount. The underwriter received 200,000 representative shares (2% of the IPO), which have a 180-day trading restriction. The SPAC has a relatively flat structure with no working capital loans described beyond the standard $20,000/month administrative services agreement with the sponsor. The company has 15 months to find a deal — a standard but non-extendable timeline absent a shareholder vote. The independent directors have typical SPAC governance roles.

The capital injection expands available acquisition funds to $115,000,000 without altering pro-rata trust accounting or triggering automatic redemption events. The April 21, 2026 settlement date moves the operating cash runway forward, compressing the timeline to identify and close a deSPAC transaction before the 2027-07-16 expiration. By publicly committing to avoid Greater China targets, the Company narrows its screening funnel, which could reduce competitive bidding for remaining Asia-Pacific assets while potentially limiting opportunity set breadth. Underwriter participation at maximum capacity signals institutional demand at the $10.00 floor price. No new extension voting thresholds, warrant/right mechanics, or sponsor forfeiture conditions were introduced.

Investors monitoring redemption calendars and trust value must treat this as an IPO commencement document rather than a deal-update notice. The company’s governing documents mandate a 15-month execution window before mandatory trust liquidation, while the prospectus calculates pro forma net tangible book value eroding from $5.43 to $0.13 per share depending on redemption volume.

The amendment sets the final economic terms of the IPO, including the trust size, redemption rights, and the timeline for finding a deal. The reduction to a 12-month deadline and the altered rights conversion ratio directly affect redemption mechanics and the pressure on management to complete a business combination. The deep discount on founder shares ($0.0062 per share) and the extensive conflicts of interest among management—who serve on up to six other SPACs simultaneously—are critical governance concerns for investors evaluating sponsor conduct and potential deal quality.

This S-1 provides the foundational prospectus for a new SPAC IPO. For investors, the critical elements are the standard trust/per-share redemption terms ($10.06 trust value per the corpus header), the 18-month (up to 21-month) deadline for a deal, and the intense conflict-of-interest disclosures: all executive officers and directors serve in similar capacities at multiple other SPACs targeting similarly-sized companies (enterprise value $180M-$1B), creating a material risk in how acquisition opportunities will be allocated. The sponsor paid only ~$0.0062/share for its founder shares, creating a significant economic incentive to close any deal versus liquidating. The filing also candidly warns that the sponsor's and management's ties to China may make it difficult to complete a non-PRC deal, increasing the likelihood of a China-based target with attendant regulatory and audit risks.

The amendment finalizes key terms of the SPAC’s IPO structure, including a longer 21-month window to find a deal, improved right conversion terms for investors, and reduced underwriting costs. These changes affect the trust value per share, potential dilution, and the sponsor’s economic incentives. The filing also provides detailed risk factors regarding China ties, PCAOB access, and conflicts of interest among management who serve on multiple SPACs. No business combination target is identified; the company remains in the early stages of searching.

Provides full disclosure of the SPAC's structure, sponsor incentives, conflicts of interest (management also serves at Quantumsphere, Quartzsea, and other SPACs), risks related to potential PRC-based targets, and the terms under which public shareholders can redeem their shares. The filing also details dilution scenarios and the sponsor's nominal cost basis, which creates misaligned incentives.

What changed: Current Report on Form 8-K filed by QuasarEdge Acquisition Corporation (QRED) announcing the entry into a material definitive agreement — an Agreement and Plan of Merger with Robseek Intelligence Inc., setting forth a definitive business combination. QRED has announced a definitive merger agreement to combine with Robseek Intelligence Inc. QRED shareholders will receive one Purchaser Class A ordinary share per QRED ordinary share; each QRED right will convert into one Purchaser right, which will be canceled at closing in exchange for one Purchaser Class A ordinary share. The implied pre-money equity value of Robseek is $1.0 billion. The sponsor (Aspira Capital Consulting LTD) has agreed to vote in favor and not to redeem its 4,025,000 founder shares. The company shareholder (Robseek Limited, holding 60,000,000 shares) has signed a support agreement. Lock-up for company shareholders is 180 days post-closing (with a potential early release if the stock trades at or above $12.50 for 20 of 30 days starting 90 days after closing). QRED’s trust held ~$116.2 million as of the signing date. The deadline to close is July 16, 2027, with extension provisions; the company (Robseek) is responsible for extension fees. Why it matters: This is the definitive deal announcement for QRED. Investors now have a concrete valuation ($1.0B pre-money for Robseek), a share count structure (100M shares to be issued at $10.00/share), sponsor conduct (no redemption, voting for), a lock-up schedule, and a mechanism for trust disbursement (redemptions first, then expenses, deferred underwriting, then notes, then balance to purchaser). The deadline is more than 12 months away (July 2027), providing a long runway. The heavy reliance on Robseek for working capital loans to the sponsor (up to $1.5M total) and for extension fees underscores that the deal is being funded almost entirely by the target, which may indicate limited SPAC cash available for redemptions or operations.

What changed: Form 8-K filed as a Rule 425 communication announcing the entry into a definitive merger agreement between QuasarEdge Acquisition Corporation (QRED) and Robseek Intelligence Inc. QRED has signed a definitive merger agreement with Robseek Intelligence Inc. The deal implies a pre-money equity valuation of $1 billion for Robseek, with Robseek shareholders receiving 100 million Purchaser ordinary shares valued at $10.00 per share. The trust fund held approximately $116.16 million as of the agreement date. Sponsor Aspira Capital Consulting LTD, holding 4,025,000 founder shares, agreed to vote in favor, not redeem, and abide by a 180-day lock-up. Company shareholders are subject to a 180-day lock-up with an early release if the stock price reaches $12.50 for 20 of 30 trading days after 90 days. The closing deadline is July 16, 2027, with extension fees payable by Robseek. The combined company board will have one director from QRED and six from Robseek. The agreement includes a $500,000 break-up fee for certain termination scenarios. Why it matters: This filing provides the first definitive terms for QRED's business combination. The $1 billion pre-money valuation is a key metric for evaluating the deal. The trust per-share value is $10.06, and redemptions will affect the cash available. Sponsor commitment not to redeem reduces redemption risk. The extended deadline gives ample time to close. The lock-up terms and board composition are standard but important for post-deal liquidity and governance. The filing includes full merger agreement, support agreements, and registration rights, offering comprehensive detail for investor analysis.

What changed: A Form 3 initial statement of beneficial ownership of securities, specifically a routine compliance insider ownership report for QuasarEdge Acquisition Corp filed with the SEC. The Form 3 filing discloses that Goldman Sachs Group Inc. holds 1,476,550 shares indirectly and identifies itself as a 10% owner. According to the submission, there is no discussion of the $10.06 trust per share, the 2027-07-16 deadline, extension procedures, deal advancement, or sponsor conduct, and the filing records no acquisition, disposition, or conversion activity beyond the stated indirect position. Why it matters: Based solely on the filing, Goldman Sachs Group Inc.’s reported 1,476,550 shares establish a 10% voting block that could significantly sway shareholder approvals for any proposed business combination or subsequent trust amendment. Because the SEC document contains no statements regarding redemption demand, trust liquidity, extension feasibility, target pipeline, or sponsor behavior, it does not modify the mechanics tied to the $10.06 reference price or the 2027-07-16 termination window. However, the registration reveals that a single 10% holder sits ready to decide whether capital remains locked in the trust or exits ahead of the 2027-07-16 deadline, which directly affects deal financing, extension ballot math, and post-redemption sponsor dilution.

What changed: A Form 8-K current report accompanied by an attached press release announcing the elective separation of underlying securities. QuasarEdge Acquisition Corp. announced on May 4, 2026, that with underwriter consent, holders may elect to separately trade the ordinary shares and rights included in its units commencing on May 7, 2026 (the press release adds “on or about May 8”). Unseparated units will continue trading under the symbol “QRED U,” while the separated ordinary shares and rights are expected to trade under the symbols “QRED” and “QRED RT,” respectively. Holders must direct their brokers to contact Continental Stock Transfer & Trust Company to execute the separation. The filing specifies that each unit consists of one ordinary share and one right entitling the holder to receive one-fourth (1/4) of one ordinary share upon consummation of the initial business combination. Regarding redemption deadlines, trust value, extensions, deal progress, or sponsor conduct, the filing reports no changes; your tracked parameters remain operationally unaffected by this administrative update. Why it matters: Decoupling the fractional rights from the base shares creates a new secondary market vehicle independent of the full-unit price, which can shift liquidity profiles, arbitrage spreads, and investor positioning ahead of a potential business combination. Because the rights only vest upon closing a merger or acquisition, the split forces the market to price the contingent equity component explicitly, potentially influencing redemption pacing if shareholders choose to hold rather than liquidate entire units. Beyond this structural mechanics update, the filing contains no substantive claims regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel. The sole named executive in the document is Chief Executive Officer and Chairman Qi Gong, who signed the 8-K, and the press release attributes all forward-looking statements and risk disclaimers exclusively to QuasarEdge Acquisition Corp.

What changed: A Current Report on Form 8-K and accompanying unaudited pro forma financial statements reporting the closing of an initial public offering and the full exercise of the underwriters’ over-allotment option. The Company states that on April 16, 2026, it sold 10,000,000 units at $10.00 per unit generating $100,000,000 in gross proceeds. On April 17, 2026, it announced the exercise of a 45-day option to purchase up to 1,500,000 additional units; closing occurred April 21, 2026 for $15,000,000 in gross proceeds. Simultaneously, the Company states that Aspira Capital Consulting Ltd. (the Sponsor) purchased 7,500 private placement units at $10.00 per unit for $75,000. The filing discloses $115,575,000 ($10.05 per unit) was placed in a trust account with Continental Stock Transfer & Trust acting as trustee. The unaudited pro forma balance sheet records $50,330 in trust interest, adjusting the trust account balance to $115,625,330. Public ordinary shares subject to possible redemption increased from 10,000,000 to 11,500,000, with an adjusted redemption value of $10.054 per share (previously $10.050). Founder shares increased from 4,495,000 to 4,532,500. An over-allotment option liability of $134,400 was reversed, and deferred offering costs including a $75,000 underwriting commission (stated as 0.50% of sale of Option Units proceeds) and $46,680 in representative shares were recorded. The filing contains no information regarding a target business, merger negotiations, extension proposals, or alterations to the July 16, 2027 liquidation deadline. Why it matters: This filing locks the post-offering capital structure and confirms the exact trust funding levels that will back shareholder redemptions. The increase from 10,000,000 to 11,500,000 public shares subject to redemption directly scales the cash required to satisfy redemption requests and establishes the $10.054 per-share benchmark cited in the pro forma statements. The Sponsor’s concurrent purchase of exactly 7,500 additional private units maintains proportional economic alignment without altering control dynamics. Because the filing is strictly a routine capitalization update, it does not move the redemption calendar, change the deal progress timeline, or indicate any shift in sponsor conduct relative to the reported July 16, 2027 window. Investors should monitor subsequent filings for any target identification or extension voting mechanics.

What changed: A Schedule 13G Joint Filing Agreement (Exhibit A) filed pursuant to Rule 13d-1(k) under the Securities Exchange Act of 1934. Seven Harraden Circle limited partnerships, two general partner entities, and individual executive Frederick V. Fortmiller, Jr. consolidated their disclosures into a single Schedule 13G report confirming collective passive beneficial ownership of QuasarEdge Acquisition Corp securities. The filing leaves the SPAC's trust value at $10.06 per share intact, preserves the original liquidation/redemption extension deadline of 2027-07-16, and introduces no amendments to the pending business combination term sheet, sponsor funding obligations, or investor tender mechanics. Why it matters: The selection of Schedule 13G over Schedule 13D indicates the Harraden Circle signatories hold a passive, non-controlling stake, which typically signals capital committed to the extended timeline rather than active efforts to accelerate a merger or trigger redemption thresholds. By executing a single joint filing agreement, the filers streamline regulatory reporting while centralizing disclosure responsibility under Mr. Fortmiller's signature, preserving independent investment discretion across the vehicles. The document contains no forward-looking statements regarding the target's projected revenue, customer concentration, market valuation, technology roadmap, strategic partnerships, or litigation exposure; all references tie exclusively to the $10.06 trust metric, the 2027-07-16 deadline, the April 24, 2026 execution date, and the SEC filing framework described by the Harraden Circle entities.

What changed: Form 8-K current report confirming the consummation of the Company’s initial public offering and accompanying private placement, submitted alongside an audited balance sheet and comprehensive financial statement notes. QuasarEdge Acquisition Corporation reported closing its IPO on April 16, 2026, issuing 10,000,000 units at $10.00 per unit, generating $100,000,000 in gross proceeds. Simultaneously, Sponsor Aspira Capital Consulting LTD purchased 270,000 private placement units for $2,700,000. The filing states that $100,500,000 of the combined net proceeds was deposited into a trust account maintained by Continental Stock Transfer & Trust Company. On April 17, 2026, the underwriters notified the Company of exercising the 1,500,000-unit over-allotment option in full, closing on April 21, 2026. This subsequent event added $15,000,000 in gross proceeds and prompted a concurrent private placement of 7,500 units to the Sponsor for $75,000. Formation and operating costs incurred between February 1, 2026, and April 16, 2026, totaled $34,049, while total transaction costs were recorded at $1,522,932. Why it matters: This report solidifies the trust value and capital deployment ahead of the July 16, 2027 business combination expiration. Public shareholders are contractually entitled to redeem shares for a pro-rata portion of the trust, which the notes calculate as initially $10.05 per public unit (or $10.00 per share plus interest/earnings per the charter). The sponsor agreed to waive redemption rights for founder and private shares and guaranteed liability to protect the trust if third-party vendor claims reduce assets below $10.00 per public share. Auditor Simon & Edward, LLP explicitly disclosed 'substantial doubt about the Company’s ability to continue as a going concern' citing the limited 15-month operational runway. Furthermore, underwriter Polaris Advisory Partners secured a 0.50% cash discount ($575,000 upon full over-allotment) and 230,000 ordinary shares as deferred compensation, alongside a 36-month right of first refusal for future advisory engagements.

What changed: A Form 3 insider ownership report filed with the SEC. Per the filing, issuer QuasarEdge Acquisition Corp designated Gong Qi (director, Chairwoman, CEO, and CFO) as the reporting person, but the document explicitly states 'No non-derivative transactions or holdings reported.' The submission records zero equity movement by the named officer. Regarding SPAC mechanics, the filing contains no data affecting redemption calculations, trust account maintenance, extension voting, or merger consideration timing; it functions solely as a statutory baseline disclosure. The publicly noted trust/share level of $10.06 and the 2027-07-16 deadline remain unchanged by this filing. Why it matters: Form 3 filings establish the legal starting point for insider equity tracking before subsequent Form 4 reports capture actual trades or exercises. By disclosing no transactions, this document offers no visible indicator of sponsor alignment, warrant exercise behavior, or secondary buying interest in the period following the deal announcement. For investors monitoring QuasarEdge, the filing signals standard regulatory compliance rather than strategic positioning, directing attention toward future Form 4 filings to determine whether leadership is accumulating shares, liquidating options, or maintaining neutrality ahead of the announced combination.

What changed: This document is a Form 3 insider ownership report, classified as a routine compliance exhibit filed pursuant to Section 16(a) of the Securities Exchange Act of 1934. Reporting person Zhang Wei, serving as a director, disclosed executing no non-derivative transactions and holding no securities in QuasarEdge Acquisition Corp during the reporting window. Consequently, the filing introduces no modifications to the trust account mechanics, redemption calendar, extension status, merger execution, or sponsor behavior. Why it matters: Because the insider disclosure registers zero equity movement by the named director, the submission neither alters available cash relative to outstanding public shares, accelerates or delays the business combination deadline, nor reflects shifting sponsor alignment. The text contains no assertions regarding customers, revenue, market size, strategy, technology, partnerships, litigation, or leadership changes; it functions exclusively as a standard 16(a) compliance record confirming routine regulatory adherence without impacting the structural timeline or redemption calculus tracked by investors.

What changed: SEC Form 3 — Initial Statement of Beneficial Ownership (routine compliance exhibit tracking insider/affiliate holdings). Aspira Capital Consulting LTD, identified as a 10% owner, filed the report disclosing a direct holding of 4,025,000 shares of QuasarEdge Acquisition Corp. Because this is a Form 3, it records the initial position rather than a subsequent transaction. The document contains no amendment to a business combination agreement, no notice regarding the trust account, no proposal to extend the 2027-07-16 deadline, and no update on deal progress or target operations. Why it matters: Mechanically, the filing verifies the sponsor/affiliate share count that sits outside the redemption pool and does not participate in the per-share trust balance ($10.06) circulating through public holders ahead of the 2027-07-16 deadline. Investors tracking redemption calendars, trust value, and sponsor conduct now have a confirmed baseline for the 4,025,000 non-redeemable shares, which fixes the promoter’s equity exposure and defines the non-redeemable denominator alongside the public float. Substantively, the filing makes no claims about customers, revenue, market size, strategy, technology, partnerships, litigation, or personnel; it is strictly a compliance artifact recording static beneficial ownership.